Sirius XM Holdings Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation Plans and Awards (Details)

Stock-based Compensation Plans and Awards (Details) (USD $)	12 Months Ended					12 Months Ended			1 Months Ended	12 Months Ended													0 Months Ended		12 Months Ended		1 Months Ended	12 Months Ended
	Jan. 31, 2013 item	Jan. 31, 2012	Jan. 31, 2011	Jul. 31, 2011	Jun. 30, 2011	Jan. 31, 2013 Stock Options	Jan. 31, 2012 Stock Options	Jan. 31, 2011 Stock Options	Jan. 31, 2011 Stock Options Spouse of executive officers	Jan. 31, 2013 Stock Options Spouse of executive officers	Jan. 31, 2013 Stock Options Black-Scholes option pricing model	Jan. 31, 2012 Stock Options Black-Scholes option pricing model	Jan. 31, 2011 Stock Options Black-Scholes option pricing model	Jan. 31, 2013 Stock Options Non-Employees	Jan. 31, 2012 Stock Options Non-Employees	Jan. 31, 2011 Stock Options Non-Employees	Jan. 31, 2013 Stock Options Minimum Black-Scholes option pricing model	Jan. 31, 2012 Stock Options Minimum Black-Scholes option pricing model	Jan. 31, 2011 Stock Options Minimum Black-Scholes option pricing model	Jan. 31, 2013 Stock Options Maximum Black-Scholes option pricing model	Jan. 31, 2012 Stock Options Maximum Black-Scholes option pricing model	Jan. 31, 2011 Stock Options Maximum Black-Scholes option pricing model	Jul. 06, 2013 Stock option with market and service conditions Mr. Joseph Kennedy	Mar. 22, 2012 Stock option with market and service conditions Mr. Joseph Kennedy	Jan. 31, 2013 Stock option with market and service conditions Mr. Joseph Kennedy Monte-Carlo simulation option pricing model	Jan. 31, 2013 Restricted stock units	Jan. 31, 2013 2011 Plan	Jan. 31, 2013 2011 Plan	Jan. 31, 2013 2011 Plan Stock Options	Jan. 31, 2013 2011 Plan Stock Options Maximum
Stock-based Compensation Plans and Awards
Share of common stock reserved for the issuance																											12,000,000	12,000,000
Share available for issuance that reserved for issuance under 2004 plan						17,791,314	10,259,069																				1,506,424	1,506,424
Annual fixed increase alternative, increase in shares of common stock reserved for issuance																												10,000,000
Annual percentage increase alternative, increase in common stock reserved for issuance as a percentage of common stock outstanding																												4.00%
Percentage increase in number of shares available for grant																											4.00%
Expiration term														10 years																10 years
Vesting term									4 years														4 years			4 years			4 years
Exercise price as a percentage of the fair market value of the common stock																													100.00%
Period for repurchase of unvested shares following termination of an individual service with company						90 days
Assumptions used to calculate per-share fair value of stock option at the date of grant
Expected life																	6 years 7 days	5 years 8 months 19 days	5 years 10 months 28 days	6 years 8 months 1 day	7 years 7 days	6 years 1 month 2 days			10 years
Risk-free interest rate, minimum (as a percent)											0.99%	1.10%	1.41%
Risk-free interest rate, maximum (as a percent)											1.52%	2.77%	2.92%
Risk-free interest rate (as a percent)																									2.33%
Expected volatility, minimum (as a percent)											56.00%	54.00%	57.00%
Expected volatility, maximum (as a percent)											57.00%	57.00%	58.00%
Expected volatility (as a percent)																									70.00%
Expected dividend yield (as a percent)											0.00%	0.00%	0.00%
Stock price (in dollars per share)				$ 16.00	$ 16.00				$ 3.14																$ 10.63
Common Stock
Number of votes per share holders of common stock are entitled	1
Number of shares early exercised			691,667
Unvested restricted shares subject to repurchase	308,334	483,334
Shares Available for Grant
Balance at the beginning of the period (in shares)						10,259,069
Additional shares authorized						11,717,956
Granted (in shares)						(1,450,000)
Restricted stock (in shares)						(484,846)																				(5,511,709)
Cancelled/Forfeited (in shares)						1,749,135
Balance at the end of the period (in shares)						17,791,314	10,259,069																				1,506,424	1,506,424
Outstanding Stock Options
Balance at the beginning of the period (in shares)						34,810,926								59,375	431,359
Granted (in shares)	800,000					1,450,000			40,000															800,000
Exercised (in shares)						(8,408,842)
Cancelled/Forfeited (in shares)						1,749,135
Balance at the end of the period (in shares)						26,102,949	34,810,926							52,000	59,375	431,359
Exercisable at the end of the period (in shares)						17,434,514
Vested and expected to vest at the end of the period (in shares)						25,432,481
Weighted-Average Exercise Price
Balance at the beginning of the period (in dollars per share)						$ 2.43
Granted (in dollars per share)						$ 10.65
Exercised (in dollars per share)						$ 0.82
Cancelled/Forfeited (in dollars per share)						$ 5.25
Balance at the end of the period (in dollars per share)						$ 3.22	$ 2.43
Exercisable at the end of the period (in dollars per share)						$ 1.48
Vested and expected to vest at the end of the period (in dollars per share)						$ 3.07
Weighted Average Remaining Contractual Term
Outstanding at the end of the period						6 years 4 months 24 days	7 years 14 days
Exercisable at the end of the period						5 years 6 months 29 days
Vested and expected to vest at the end of the period						6 years 4 months 2 days
Aggregate Intrinsic Value
Aggregate intrinsic value (in dollars)						$ 224,736,000	$ 379,355,000
Exercisable at the end of the period (in dollars)						178,135,000
Vested and expected to vest at the end of the period (in dollars)						222,779,000
Fair value of common stock (in dollars per share)						$ 11.52	$ 13.19	$ 3.14
Unrecognized compensation cost						31,000,000								400,000											3,600,000		313,500,000	313,500,000
Weighted average period for recognization of unrecognized compensation	4 years					2 years 4 months 24 days								1 year 9 months 18 days											4 years 5 months 5 days	3 years 3 months 18 days		2 years 4 months 24 days
Stock-based compensation expense	25,500,000	9,178,000	1,455,000							100,000				200,000	300,000	15,500										10,400,000
Options Granted:
Consulting services period									4 years
Options granted to consultant (in shares)	800,000					1,450,000			40,000															800,000
Stock price (in dollars per share)				$ 16.00	$ 16.00				$ 3.14																$ 10.63
Vesting term									4 years														4 years			4 years			4 years
Vesting percentage									2.08%
Initial grant date fair value of options									60,000
Stock-based compensation expense	25,500,000	9,178,000	1,455,000							100,000				200,000	300,000	15,500										10,400,000
Period of time that the trailing weighted average stock price must exceed a certain price for the stock award to vest, prior to July 6, 2017																								60 days
Share price, under a sale of the entity, that must be obtained for the stock award to vest prior to July, 6, 2017 (in dollars per share)																								$ 21.00
Share price that must be obtained for the stock award to vest prior to July, 6, 2017 (in dollars per share)																								$ 21.00
Weighted-average fair value of stock option granted (in dollars per share)						$ 5.91	$ 4.83	$ 1.17																	$ 6.08
Number of Shares
Unvested at the beginning of the period (in shares)																										1,426,975
Granted (in shares)																										4,864,000
Vested (in shares)																										(400,112)
Cancelled (in shares)																										(379,154)
Unvested at the end of the period (in shares)						484,846																				5,511,709
Expected to vest at the end of the period (in shares)																										5,002,948
Weighted-Average Grant-Date Fair Value
Unvested at the beginning of the period (in dollars per share)																										$ 12.03
Granted (in dollars per share)																										$ 10.37
Vested (in dollars per share)																										$ 12.20
Cancelled (in dollars per share)																										$ 11.77
Unvested at the end of the period (in dollars per share)																										$ 10.57
Expected to vest at the end of the period (in dollars per share)																										$ 10.59
Stock-based Compensation Expenses
Total grant date fair value of stock options vested						13,000,000	5,000,000
Intrinsic value of options exercised						84,900,000	51,900,000	5,800,000
Fair value of options vested						13,100,000	5,200,000	909,000
Compensation cost not yet recognized																										51,700,000
Number of awards modified							3,600,000
Incremental stock-based compensation expense						$ 0	$ 2,300,000